Michael joined NEA in 2022 as an Associate on the Healthcare Team focused on investments in life sciences. Prior to joining NEA, Michael was a member of the Healthcare Investment Banking Group at Goldman Sachs in New York City, where he worked on various financing and M&A transactions across biopharma. Michael also spent time conducting acute myeloid leukemia research at Weill Cornell Medical College and Imperial College London.

Michael graduated from Northwestern University with a bachelor's degree in Neuroscience. He is originally from the suburbs of New York City.